Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6833471rdf:typepubmed:Citationlld:pubmed
pubmed-article:6833471lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:6833471lifeskim:mentionsumls-concept:C0014912lld:lifeskim
pubmed-article:6833471lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:6833471lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6833471lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:6833471lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:6833471lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:6833471pubmed:issue5lld:pubmed
pubmed-article:6833471pubmed:dateCreated1983-5-27lld:pubmed
pubmed-article:6833471pubmed:abstractTextObesity is associated with an increased incidence of reproductive dysfunction and estrogen-linked diseases. In the present study, we have examined the principal oxidative biotransformations of estradiol in 13 obese premenopausal females and 10 obese males compared to those in 9 premenopausal female and 15 male controls. These studies were carried out using a recently devised, sensitive radiometric method which permits the assessment of the total in vivo oxidative metabolism of estradiol at specific sites (i.e. 17 alpha, 16 alpha, or C-2) on the steroid molecule. Our results indicate that obesity (greater than 60% above ideal body weight) is associated with significant decreases in hydroxylation at C-2 in both sexes (P less than 0.001 for females and P less than 0.02 for males) and in oxidation at 17 alpha in premenopausal females (P less than 0.05) compared to that in age-matched, normal weight controls. Analysis of the plasma 3H2O specific activity curves suggested a slight decrease in the rate of 17-oxidation in obese subjects. The extent of hydroxylation at 16 alpha was not significantly affected by obesity. These metabolic alterations documented in obesity could result in a relative hyperestrogenic state, since, unlike the other estrogen metabolites, the 2-hydroxyestrogen compounds display relatively little peripheral estrogenic activity. This metabolic alteration on a prolonged basis might be contributory to the prevalence of certain hormonally related diseases in obese individuals.lld:pubmed
pubmed-article:6833471pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6833471pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6833471pubmed:languageenglld:pubmed
pubmed-article:6833471pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6833471pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6833471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6833471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6833471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6833471pubmed:statusMEDLINElld:pubmed
pubmed-article:6833471pubmed:monthMaylld:pubmed
pubmed-article:6833471pubmed:issn0021-972Xlld:pubmed
pubmed-article:6833471pubmed:authorpubmed-author:LevinJJlld:pubmed
pubmed-article:6833471pubmed:authorpubmed-author:AndersonKKlld:pubmed
pubmed-article:6833471pubmed:authorpubmed-author:SchneiderJJlld:pubmed
pubmed-article:6833471pubmed:authorpubmed-author:FishmanJJlld:pubmed
pubmed-article:6833471pubmed:authorpubmed-author:BradlowH LHLlld:pubmed
pubmed-article:6833471pubmed:authorpubmed-author:StrainGGlld:pubmed
pubmed-article:6833471pubmed:issnTypePrintlld:pubmed
pubmed-article:6833471pubmed:volume56lld:pubmed
pubmed-article:6833471pubmed:ownerNLMlld:pubmed
pubmed-article:6833471pubmed:authorsCompleteYlld:pubmed
pubmed-article:6833471pubmed:pagination973-8lld:pubmed
pubmed-article:6833471pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:meshHeadingpubmed-meshheading:6833471-...lld:pubmed
pubmed-article:6833471pubmed:year1983lld:pubmed
pubmed-article:6833471pubmed:articleTitleEffects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites.lld:pubmed
pubmed-article:6833471pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6833471pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6833471pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6833471pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6833471lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6833471lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6833471lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6833471lld:pubmed